Gilead Sciences (GILD)
Nasdaq
Gilead Sciences Chart
Gilead Sciences (GILD) stock price, session move and chart. GILD stock news and the latest available quote on NASDAQ.
Current Gilead Sciences forecasts and price targets
Analyst figures are shown only when the research feed provides them.
Scroll here to load data.
People also watch
Trending global stocks
Related in Drug Manufacturers—General
About Gilead Sciences
Gilead Sciences, Inc. () is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.…
From the companyLearn about the biopharmaceutical company Gilead Sciences, including mission, vision, values, history, impact, leadership, therapeutic areas and other information.
Company profile
Gilead Sciences executives and management
Gilead Sciences earnings date
Gilead Sciences stock research: financials and ownership
Gilead Sciences revenue, operating income and earnings per share
Annual figures are charted only when the provider supplies comparable periods.
Scroll here to load data.
Key financial metrics
Financial Highlights
| Profit Margin | N/A |
| Operating Margin | N/A |
| Return on Assets | N/A |
| Return on Equity | N/A |
| Revenue | N/A |
| Quarterly Revenue Growth | N/A |
| Diluted EPS | N/A |
Balance Sheet
| Total Cash | N/A |
| Total Debt | N/A |
| Total Debt/Equity | N/A |
| Current Ratio | N/A |
| Book Value Per Share | N/A |
Cash Flow Statement
| Operating Cash Flow | N/A |
| Levered Free Cash Flow | N/A |
Share Statistics
| Avg Vol (3 month) | 5.00M |
| Shares Outstanding | 1.25B |
| Float | N/A |
| Short Ratio | N/A |
| Short % of Float | N/A |
Major Holders
| % of Shares Held by All Insiders | N/A |
| % of Shares Held by Institutions | N/A |
| % of Float Held by Institutions | N/A |
| Number of Institutions Holding Shares | N/A |
Financial statement fields will appear when the market-data feed provides usable fundamentals for this instrument.
Gilead Sciences revenue by segment
Scroll here to load data.
Gilead Sciences revenue by region
Scroll here to load data.
Gilead Sciences stock margins
Scroll here to load data.
Gilead Sciences historical valuation
Scroll here to load data.
Gilead Sciences annual returns
Scroll here to load data.
Gilead Sciences financial statements
Income statement, balance sheet and cash flow, with annual and quarterly periods.
Scroll here to load statements.
Related Articles & Updates
TechGraph News · 2026-10-18The Connected Exchange: NCDEX CTO Balkrishna Shankwalker on the Future of the Commodity Market
TechGraph News · 2026-10-15NumanCap Review 2026 | Markets, Margin and Mobile
TechGraph News · 2026-10-01What Does India’s First Tokenised Bond Pilot Mean for the Debt Market?
TechGraph News · 2026-09-15Javier Olivan Plans $1.04 Million Meta Share Sale
TechGraph News · 2026-09-13NVIDIA Awards 172,507 Shares to EVP Nicholas Parker
TechGraph News · 2026-09-13Meta CPO Chris Cox Sells Shares Worth $13 Mn
Gilead Sciences fair value
Scroll here to load data.
Gilead Sciences options chain
Scroll here to load data.
Gilead Sciences — frequently asked questions
What is the Gilead Sciences stock price?
The Gilead Sciences (GILD) stock price is the live quote at the top of this page. Gilead Sciences trades on Nasdaq.
Where is the GILD stock quote and news?
The GILD stock quote, chart and news are on this page.
Where is Gilead Sciences listed?
Gilead Sciences trades as GILD on Nasdaq.
Price quotes refresh periodically while this page stays open; the chart follows the quote and refreshes exchange history less often. Some venues delay data by 0–15 minutes. When the market is closed, the last recorded session price is shown. Fundamentals refresh on a slower schedule.